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Abstract
The boron nitride (BN) nanoparticles, as the structural analogues of graphene, are the potential biomedicine materials
because of the excellent biocompatibility, but their solubility and biosafety are the biggest obstacle for the clinic
application. Here, we first synthesized the highly soluble BN nanoparticles coated by PEG (BN-PEG) with smaller
size (~10 nm), then studied their biodistribution in vivo through radioisotope (Tc99mO4
−) labeling, and the results
showed that BN-PEG nanoparticles mainly accumulated in the liver, lung, and spleen with the less uptake by the
brain. Moreover, the pathological changes induced by BN-PEG could be significantly observed in the sections of
the liver, lung, spleen, and heart, which can be also supported by the test of biochemical indexes in serum. More
importantly, we first observed the biodistribution of BN-PEG in the heart tissues with high toxicity, which would give a
warning about the cardiovascular disease, and provide some opportunities for the drug delivery and treatment.
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Background
The two-dimensional (2D) materials are a single-atom-
layer materials with some special properties [1–3]. At
present, the most famous 2D material is the carbon 2D
nanomaterials namely graphene because of its excellent
physicochemical properties [4–6]. Moreover, the boron
nitrides, known as white graphene [7], have received
more and more attention. BNs are structural analogues
of graphene in which C atoms are replaced by alternat-
ing B and N atoms. Moreover, thanks to the special
chemical and physical characteristics of the BN nanopar-
ticles, many researchers have found a large number of
applications in the field of nanotechnology, and several
studies have shown their possible exploitation in the
biomedical domain, such as nanocarriers [8] and nano-
transducers [9]. However, before the clinical application,
it is very necessary and important for biomaterials of BN
to investigate biosafety in vivo and in vitro. Biosafety in-
vestigations include toxicity in vivo and cytotoxicity in
vitro; to clarify toxicity in vivo, it was essential a pre-
requisite to research its behavior and fate in the living
things. Unfortunately, so far no one has explored the de-
tailed investigations about behavior and toxicity of BN in
vivo.
Considering that the pristine BN materials are hardly
used in the biomedical domain due to the profound
chemical inertness of insoluble BN structures [10], so, a
layer of hydrophilic material such as polyethylene glycol
(PEG) was often coated on the surface of pristine BN for
improving the solubility and enhancing the biological
compatibility [11]. Moreover, the PEG that was thought
as a safe and innocuous biomaterial is widely used to
improve the biological compatibility and water solubility
of various nanoparticles [12–14]. Furthermore, the coat-
ing of PEG would not alter the structure of BN and re-
main the property and character of BN, which would
increase the application prospects of BN materials [15].
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Thereby, Weng et al. [10] successfully prepared the coat-
ing of porous BN materials with PEG, which preformed
the lower cytotoxicity. However, the cytotoxicity of the
porous BN may be different to that of entire BN. There-
fore, it would be very imperative to study the behavior and
toxicity of entire structure of BN after coating with PEG.
In current works, we found that some PEG-coated BN
(BN-PEG) nanoparticles with smaller sizes (~10 nm) and
quantum effects could be easily prepared through the
treatment of PEG coating, but lower fluorescence quantum
yield (~7.8 %) would be not conducive to detect signals
from biological samples. Although a fluorescent labeling
and imaging may be a popular method to study BN-PEG
in vivo, but the potential quenching and other intrinsic
limitations of fluorescence imaging could cause nonquanti-
tative and less accurate biodistribution results [10]. In com-
parison, the pharmacokinetics and biodistribution studies
based on 99mTc-labeled, BN-PEG provides more reliable
and quantitative information for the in vivo behaviors of
biocompatibility functionalized BN [10]. Therefore, here,
we prepared the BN-PEG nanoparticles with high water
solubility, and then 99mTcO4
− was used to label complexes,
and studied the biodistribution and toxicity of BN-PEG in
mice in vivo.
Methods
Synthesis and Characterization of PEG-Coated BN
A solution of 6-arm-polyethyleneglycol-amine (Sunbio
Inc.) (3 mg/mL) was mixed to the BN sheets (0.5 mg/mL)
(BN were purchased from Baoding Zhong Pu Rui Ta tech-
nology. LTD), and the mixture was stirred at 200 °C for
4 days under a steady nitrogen flow. After cooling the reac-
tion mixture to a room temperature, then H2O (~60 mL)
was added for extraction [16]. The solution was sonicated
and centrifuged (~5000g, 20 min), and the supernatants
were collected and dialyzed about 1 week by dialysis
membrane (MD25) to remove free PEG. Finally, the so-
lution was dried at 50 °C in vacuum oven, and the solid
product was the BN-PEG. And then, the product was
characterized by TEM (Tecnai G2 F30), XRD (XRD-
600) and fluorescence lifetime and steady-state spec-
troscopy (FLS; 920).
99mTc Labeling BN-PEG
The 99mTc labeling of BN-PEG and determination of la-
beling yields were performed [17] (99mTcO4
− was pur-
chased from the China Institute of Atomic Energy,
Beijing, China; 5 mCi). BN-PEG was dissolved in deion-
ized water with an ultrasonic device for 30 min. Ascorbic
acid, stannous chloride, and 99mTcO4
− were then added
into the suspension. This mixture was stirred at 90 °C for
30 min. After centrifugation, the supernatant was dec-
anted, and the remaining solid was identified to be 99mTc-
BN-PEG. The radiolabeling yields of 99mTc-BN-PEG were
measured by paper chromatography using Whatman 1
paper strips (Maidstone, Kent, UK) (Fig. 1). Consider-
ing the short lifetime of 99mTc (6.02 h), we measured
the radio counts in 1 day for accurate determination of
the tag. Otherwise, the tag (99mTc) would decay in 10
half times.
The Biodistribution of BN-PEG
Kunming mice initially weighing 15 to 18 g were provided
by the Laboratory Centre for Medical Science, Lanzhou
University, Gansu, China. All animals were housed in indi-
vidual cages in a temperature-controlled (21 to 22 °C) and
light-controlled (turned on from 0800 h to 2000 h) envir-
onment and were fed food and tap water ad libitum. All
animal protocols were in accordance with the European
Communities Council Directive of November 24, 1986 (86/
609/EEC) and approved by Institutional Animal Care and
Use Committees of Gansu Province Medical Animal Cen-
ter and Lanzhou University Animal Committees Guide-
line (China). The mice were organized randomly into
four groups (six mice/group). The mice were injected
intravenously with 20 mg/kg bw of 99mTc-BN-PEG so-
lution (pH = 7.26, CNaCl = 0.9 %), and then killed at 1, 6,
16, and 24 h after injection. Tissues from the heart,
lung, liver, spleen, kidney, stomach, and brain were im-
mediately dissected, and the blood was also collected.
Each tissue was wrapped in foil, weighed and counted
for 99mTc. Data were corrected for physical decay of
radioactivity. The distribution of the tissues was pre-
sented in percent injected dose per gram of wet tissue
(%ID/g), which could be calculated by the percent
injected dose (tissue activity/total activity dose) per
gram of the wet tissue.
Blood Analysis and Histology Examinations
CRP, ANP, BUN, and TB kits were purchased from Shang-
hai Heng Hitter Trade Co., Ltd. and then kept in the re-
frigerator at 4 °C. Approximately 0.2 mL of BN-PEG
(20 mg/kg bw) was injected intravenously to the experi-
mental mice (six mice). Approximately 0.2 mL of saline
solution and PEG (20 mg/kg bw) was administered to the
mice from the control groups. All mice were then killed.
Approximately 2 mL of blood was collected to obtain the
plasma, and then centrifuged for 10 min to collect the
serum. The serum contents of CRP, ANP, BUN, and TB
were then measured. At the same time, the liver, lung,
spleen, kidney, and heart were harvested immediately.
These tissues were fixed in 10 % buffered formalin and
processed for routine histology with hematoxylin and
eosin staining by the Centre for Medical Science, Lanzhou
University (Lanzhou, China). Microscopic observation of
tissues was performed with an Olympus Microphot-CX41
microscope coupled with a digital camera.
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Results and Discussion
The Preparation and Characterization of BN-PEG
The Fig. 1 showed the image of raw BN and BN-PEG
from the TEM, which showed that the morphology of
raw BN is very disordered. After coating with PEG, the
size of BN-PEG became relatively uniform and smooth
with clear stripe structure of 2D, which may be due to
that bigger size of BN was removed in the process of
preparation. Further characterization of XRD showed
that BN-PEG has peaks of PEG and BN, and the peak
intensity of PEG is much higher than BN in the BN-
PEG, showing that degree of coating with PEG is high,
so we observed high water solubility in solution of BN-
PEG (Fig. 2). The TGA of BN-PEG was shown in Fig. 3;
the losing weight of PEG was presented at 412 °C, but
because BN was very stable in high temperature or in
flames, and so the losing weight of BN was only about
3.74 % until 800 °C. Compared to the TGA results of
single PEG and BN, the residues represented the BN
nanoparticles (~86.58 %) but the losing weight of PEG
was (~11.42 %) in BN-PEG (Fig. 3), which may be owing
to scale screening of BN-PEG. In this work, the bigger
scale nanoparticles of BN-PEG were removed by centri-
fugal separation, so we selected the small scale nanopar-
ticles of BN with PEG (Fig. 1). However, high content of
PEG in small size of BN-PEG would also exist high
solubility and biological compatibility (Fig. 4), but which
causes the characteristic absorption bands of BN in BN-
PEG can hardly be observed by XRD (Fig. 2).
Biodistribution of BN-PEG Through Labeling of 99mTc
BN is insoluble in water, but it would be dissolved easily
in water after coating with PEG. The PEG contained
many hydroxy groups, so the unfilled electron orbits of
Tc(V) were filled immediately by electrons donated by
Fig. 2 XRD characterization of raw BN, PEG, and BN-PEG (the lattice
spacing for (002) is 0.33 nm and for (100) is 0.217 nm)
Fig. 1 TEM characterization of raw BN (a, c) and BN-PEG (b, d); c and d are the high-resolution optical picture of the limiting region in a and
b, respectively
Liu et al. Nanoscale Research Letters  (2015) 10:478 Page 3 of 7
four hydroxy groups from BN-PEG. Stable chelate com-
pound 99mTc-BN-PEGs were formed with high labeling
rate (Fig. 5a). It was reported that, after single exposure
to Na99mTcO4, most are cleared quickly by urine without
obvious retention in the organs [18]. However, in this
study, we observed that 99mTc-BN-PEG was highly dis-
tributed in the liver, spleen, and other organs of mice in
24 h after injection. These results suggest that the label-
ing compounds have tracer properties and can effectively
respond to the behavior of BN in vivo. The radiolabeling
yields of 99mTc-BN-PEG were determined by paper chro-
matography, with normal saline as the solvent (Fig. 5a).
The radiolabeling yields were over 90 %.
The Fig. 5b showed that BN-PEG was mainly distributed
in the liver and spleen in 24 h but with lower distribution
in the lung, interestingly, which is different with the biodis-
tribution of other carbon nanoparticles [19, 20]. In our pre-
vious works [21–23], we reported that the distribution in
the lung and stomach is the highest for the graphene oxide
(GO), carbon nanotubes, and nano-diamond mainly. How-
ever, the distribution of BN-PEG has a good agreement
with graphene oxide coated by PEG [24]; the BN and GO
coated by PEG mainly accumulated in the reticuloendothe-
lial system (RES) such as the liver and spleen (Fig. 5b),
meaning that the coating of PEG affected and changed the
behavior and fate of the nanoparticles in vivo. The high
distribution of BN/GO-PEG in macrophage organs could
be attributed to Kupffer cells which could devour the
nanoparticles so as to decrease the tissues toxicity, but the
high accumulation in the lung is owing to capture role of
the pulmonary capillary bed on nanoparticles [18]. After
coating with PEG, the nanoparticles containing BN and
graphene would pass through the pulmonary capillary bed,
and entered into the liver and spleen with the development
of the circulation of the blood; in here, most of them would
be devoured by the Kupffer cells. The finding of the pro-
cesses would be useful and important for us to protect and
cure worker from harm of BN, and it would provide some
new route to design the drug delivery system of BN.
Moreover, the peak of biodistribution of BN-PEG is at
about 16 h post injections (Fig. 5b), but which is incon-
sistent with the dynamics of GOs (~2 h) [23], and this
may be due to the structure difference of BN and GOs.
We also found lower distribution of BN-PEG in the kid-
ney and brain tissues (Fig. 5b). The kidney is the excre-
tory system of nanoparticles through urine, and some
papers have reported that the nanoparticles can be ex-
creted by the urine with high biodistribution in the kidney,
showing that the BN-PEG could be excreted with develop-
ment of time, so the distribution in kidney increased
slowly and reached the peak at 24 h (Fig. 5b). The biodis-
tribution of BN-PEG in the brain was first reported for
most of the nanoparticles in this work. It is generally
accepted that the carbon nanoparticles and metal nanoma-
terials could not pass through blood-brain barrier, so it is
very hard to deliver drug with these nanoparticles [25–27].
However, we found a degree of enrichment in brain with
slow elimination, so we conferred that the BN-PEG would
be able to pass through the blood-brain barrier. The result
would be valuable to design the drug delivery system of
BN-PEG for curing the disease in brain.
Fig. 3 TGA of BN, PEG, BN-PEG (the samples were made under pro-
tection N2 with a flow speed about 0.06 L/min)
Fig. 4 The study of water-soluble in 0.5 min and 24 h, a 0.5 min; b 24 h. The brown is the BN-PEG; the white is the pristine BN
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Histopathology
The sections of organic tissues were cut to perform
microscopic examination, and shown in Fig. 6. The re-
sults showed that the BN-PEG nanoparticles could cause
the extensive injury on tissues contained from the liver,
spleen, kidney, lung, and heart, and the control groups
of normal saline and single PEG are normal. The cell
lineage disorder, hepatic lobules disappeared, and hydro-
pic degeneration with focal inflammation could be ob-
served from the liver section. The splenic sinus eclasis,
Fig. 5 The labeling yields of 99mTc-BN-PEG were measured by paper chromatography (a); and their biodistribution in the blood, heart, liver,
spleen, lung, kidney, stomach, and brain of mice at 1, 6, 12, and 24 h after exposure to 99mTc-BN-PEG (b) (±sem, n = 6)
Fig. 6 The tissue histology sections after exposure to normal saline, PEG, and BN-PEG to mice
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size disorder of follicular, hyperplasia of extramedullary
hematopoietic giant cells and small vessels could be seen
from the spleen section. Alveolar wall thickening, epithe-
lial cell proliferation, intraluminal secretions, bronchial
epithelial disorder, and proliferation of interstitial small
blood vessels could be found in lung tissues. The lesion
of the kidney could also be observed with glomerular
swelling, smaller glomerular capsular, mesangial cell pro-
liferation. Interestingly, we could also observe the severe
lesion from pathological section of the heart tissue, al-
though muscle fibers are still arranged neatly, slightly
striated muscle cell proliferation with increased cell nu-
cleus. As can be seen from these results, the toxicity of
BN-PEG is very strong, the toxicity of nanoparticles on
the lung, liver, spleen, and kidney were reported in many
papers [21–23]. However, the striated muscle cell prolif-
eration and the increased cell nucleus would result from
myocardial hypertrophy, further inducing heart failure.
Abdelhalim M.A.K [28] reported that the gold nanopar-
ticles (~200 nm) (GNP) could induce the heart injury,
and they thought that the pathological changes may be
the results from GNPs interference with the antioxidant
defense mechanism. While they also conferred that the
pathological changes would be more obvious for the
smaller size of nanoparticles, which would cause signifi-
cantly greater oxidative stress. In this work, in comparison
with graphene, although their thickness is single atom
layer, the size of BN-PEG is very small (10–20 nm), so it
would led to a stronger oxidative stress so as to induce le-
sions in the heart. Moreover, the BN-PEG nanoparticles
could also be observed clearly in section of some tissues
contained from the heart and kidney, interestingly, it
could not be found obviously in the lung and liver with
high distribution. The carbon nanoparticles such as gra-
phene oxides, fullerenes, and carbon nanotubes were seen
in the lung, liver, and spleen clearly; our previous papers
referred that a few nanoparticles of graphene oxides could
be observed in the kidney, which is owing to the excretion
of nanoparticles through urine [22, 23]. The size of BN-
PEG nanoparticles were much smaller than the graphene
oxides. Next, these tissue lesions would be studied deeply
through the test of biochemical indicators.
The Biochemical Characteristics in Serum
To reveal any potential toxic effect of BN-PEG on the
liver and heart of the treated mice, we also carried out
the test of blood biochemistry. Mice injected respectively
with the mixed solution of normal saline, and 0, 300,
and 500 μg BN-PEG were sacrificed at 24 h for blood
collection (six mice per group). Various biochemistry pa-
rameters were tested with particular attention paid to
the liver and kidney function markers including cystatin
C (Cys-C), creatinine (CREA), alanine aminotransferase
(ALT), aspartate transaminase (AST), total bilirubin
(TB), C-reactive protein (CRP), and blood urea nitrogen
(BUN), then these parameters would be compared with
control groups (0 μg) using SPSS software, p < 0.05 de-
notes a significant difference, all results were shown in
the Fig. 7. We cannot find the significant difference of
BUN and Cys-C between exposure and control groups,
because BUN and Cys-C are sensitive to the physio-
logical function of kidney. So, this may suggest that the
exposure of BN-PEG did not damage the kidney func-
tions. However, TB is also an index for reflecting the
Fig. 7 Effect of BN-PEG injection dose on biochemistry index contents in serum in vivo in mice. *p< 0.05 for groups vs. control group (0ug); ±sem. n= 6
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change of kidney function, as compared with normal
groups; we found that TB content decreased significantly
by exposure of 100 μg/mouse BN-PEG, increased signifi-
cantly by exposure of 300 and 500 μg/mouse BN-PEG,
suggesting that to some degree, the kidney function can
be affected by exposure to BN-PEG. ALT, AST, CREA,
and TB are sensitive to the liver function; Fig. 7 shows
that contents in serum of AST, ALT, and CREA can be
significantly changed after injection with 100 or 500 μg/
mouse BN-PEG, and meaning that injection of BN-PEG
can lead to abnormal liver function, which is consistent
with other references. Interestingly, we have found high
accumulation in heart, which may indicate that BN-PEG
would damage heart tissue, so, we also test the CRP in
serum as a sensitive index to the heart. As compared
with control group, the content of CRP can be decreased
by the exposure of 100 μg/mouse BN-PEG, with the in-
crease of injection doses, the content of CRP in serum
would return back to normal level. This indicates that
the BN-PEG with certain dose may damage the heart
function as a result of high biodistribution of heart, but
detailed mechanism needs further study in the future. In
a word, although the covering of PEG on surface of BN
can improve the water solubility and biocompatibility;
exposure of high-dose BN-PEG is still very dangerous
for animals in vivo.
Conclusions
The BN is a poorly water-soluble nanoparticle, so the
data of its in vivo biodistribution and safety is unclear
up to now. Therefore, the highly soluble BN-PEG was
prepared by an improvement of existing methods, and
we, for the first time studied in vivo biodistribution and
biotoxicity of BN-PEG by a radiolabeling method in
mice. Both biodistribution measurements based on
99mTc labeling suggest that the BN-PEG mainly distrib-
uted in the liver, spleen, and lung, and observations from
histological slices show that it could cause obvious tissue
lesions in liver, spleen, lung, and heart. The heart damage
is a novel and interesting finding for understanding and
treating the toxicity of BN nanoparticles on mice; the test
of biochemistry parameters including Cys-C, CREA, ALT,
AST, TB, CRP, and BUN in serum further confirms the
result. Therefore, the BN-PEG nanoparticles are the haz-
ardous materials in vivo, and its biologic toxicity could be
taken seriously.
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